Update on SARS-CoV-2 Research (1)

Some data on Pfizer’s clinical canditate. Source: [10]
Representation of the different scenarios possible based on the T-cell cross-reactivity observed in some patients. Source: [12]
  1. https://bit.ly/34yaQ7K
  2. https://bit.ly/372qfQz
  3. https://bit.ly/3lK7BkE
  4. https://bit.ly/34YwJ0l
  5. https://bit.ly/3m4JJIJ
  6. https://bit.ly/2IcwKG7
  7. https://bit.ly/2SAWuhg
  8. https://bit.ly/3nECcSs
  9. https://bit.ly/36VAdDc
  10. https://bit.ly/34IWjGl
  11. https://bit.ly/3jT6PkI
  12. https://go.nature.com/37jVIxW




Love podcasts or audiobooks? Learn on the go with our new app.

Recommended from Medium

A quick PSA for those afraid to get the COVID vaccine as cases spike.

6 Ways to Stay COVID-Safe This Holiday Season

The Importance of Evolutionary Biology in Understanding Public Health during a Pandemic

Following the Science

COVID Vaccine Mandates Apply to Many Workers in Washington State

Vaccine Mandates

Read This Before You Go to the Dentist

Facing the Reality of Covid-19 is Less Scary Than Wishful Thinking

Contact Tracing 101: How It Works and What to Expect

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Michael Bogdos

Michael Bogdos

More from Medium

The Vision of Pastoring: CEO or Ancient Near-Eastern Shepherd

It’s A Good Thing College Football Sucks

There Is An Island Beyond The Horizon

Can a Language Change Its Alphabet?